Benzinga's Top #PreMarket Losers
January 22, 2014 at 08:26 AM EST
AMAG Pharmaceuticals (NASDAQ: AMAG ) shares fell 16% to $18.38 in the pre-market trading after the company received a CRL from the FDA for the supplemental NDA for Feraheme for broader IDA indication. Coach (NYSE: COH ) dipped 5.86% to $49.47 in the pre-market session after the company reported
